Rich Morris

Rich Morris Headshot.png

Mr. Morris is an accomplished senior finance executive who has spent over 20 years in the life science industry, most recently as Chief Financial Officer of Vitae Pharmaceuticals, which was acquired by Allergan PLC for $639 million in November 2016. In this capacity, he led the company’s multiple public offerings and raised over $130 million. Prior to Vitae, Rich spent 12 years at ViroPharma Incorporated. He was Vice President - Financial and Strategic Planning when the company was acquired for $4.2 billion by Shire Pharmaceuticals. In addition to leading finance teams in the US, Rich provided finance leadership for multiple product launches, product in-licensing and acquisitions and oversight for European operations and was a member of the company’s European Business Unit Board and of the International Business Unit Board.

Rich began his career with KPMG, LLP in their Healthcare and Life Science practice. Rich holds a Bachelor of Science degree in Accounting from Saint Joseph’s University in Philadelphia and is a Certified Public Accountant in the state of Pennsylvania.